Opendata, web and dolomites

LION-HEARTED SIGNED

Light and Organic Nanotechnology for Cardiovascular Disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LION-HEARTED project word cloud

Explore the words cloud of the LION-HEARTED project. It provides you a very rough idea of what is the project "LION-HEARTED" about.

population    efficient    economical    perfusion    outcome    respect    hearted    models    treatment    virtually    minimally    restore    electrical    synergistic    phototransducers    semiconductors    blood    systemic    dependence    cardiovascular    trigger    realization    mortality    care    gene    optical    possibility    poor    incidence    consequence    animal    final    preserve    rescue    aging    unprecedented    unfortunately    life    organic    stage    socio    pharmacological    disease    daily    progression    disorders    givers    light    worldwide    negative    proliferation    resident    proof    implantable    ischemic    vascularization    stimulating    molecular    endothelial    act    strategy    reparative    invasive    nanotechnology    least    invasiveness    survival    insult    hf    biocompatible    morbidity    repair    platform    circumvent    lion    efficacy    circulating    modulation    modulating    greatest    cells    types    homing    pharmaceutical    biological    cell    combination    reverse    stenosis    heart    transplantation    resolution    point    function    fate    spatio    cardiac    selectivity    phenotype    quality    cv    optoceutic    temporal    urgently    hurdles    displays    lacking    patients    therapies    aneurysm    disruption    huge    device    progenitors    breakthrough    limiting    vivo    lower    cardiomyocytes   

Project "LION-HEARTED" data sheet

The following table provides information about the project.

Coordinator
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA 

Organization address
address: VIA MOREGO 30
city: GENOVA
postcode: 16163
website: www.iit.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 2˙904˙413 €
 EC max contribution 2˙904˙413 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-2018-2019-2020-01
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2023-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA IT (GENOVA) coordinator 509˙458.00
2    CHARITE - UNIVERSITAETSMEDIZIN BERLIN DE (BERLIN) participant 489˙730.00
3    HUMANITAS MIRASOLE SPA IT (ROZZANO (MI)) participant 450˙000.00
4    UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA ES (LEIOA) participant 313˙475.00
5    UNIVERSITA DEGLI STUDI DI PAVIA IT (PAVIA) participant 305˙000.00
6    UNIVERSITAT LINZ AT (LINZ) participant 285˙250.00
7    ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA IT (BOLOGNA) participant 279˙250.00
8    TECHNISCHE UNIVERSITAET MUENCHEN DE (MUENCHEN) participant 272˙250.00

Map

 Project objective

Cardiovascular (CV) disease is the leading cause of mortality and morbidity worldwide, with an increasing incidence in the aging population and a huge socio-economical impact. Heart failure (HF), the common end point of virtually all CV disorders, displays the greatest negative impact on quality of life, leading to the disruption of daily management and increasing dependence on care-givers. Unfortunately, an effective pharmacological treatment is currently lacking, as it is not possible to reverse disease progression; as a consequence, the long-term survival remains poor, and heart transplantation is the only possibility for end-stage HF patients. Thus, a breakthrough approach to preserve or, at least, restore cardiovascular function and to rescue systemic blood perfusion is urgently required. LION-HEARTED will demonstrate a novel optoceutic platform, based on synergistic combination of light and organic nanotechnology, to restore cardiac function and vascularization, by modulating fate and proliferation of main cardiovascular cell types. Optical modulation will provide unprecedented spatio-temporal resolution, lower invasiveness, and higher selectivity in respect to traditional electrical and pharmaceutical control methods. Organic semiconductors will act as efficient, highly biocompatible phototransducers, able to trigger biological pathways relevant to cardiac repair, with a minimally invasive and gene-less approach. This strategy will circumvent most of the hurdles currently limiting the efficacy of molecular therapies, by directly stimulating the reparative phenotype of resident cardiac progenitors, cardiomyocytes, and of circulating endothelial cells homing towards the heart after an ischemic insult. The final outcome will be the realization of a proof of concept, implantable device for enhancing cardiac repair in ischemic, aneurysm and stenosis in vivo animal models.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LION-HEARTED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LION-HEARTED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

BRIEFING (2018)

Bridging the FET Innovation Gap

Read More  

ATEMPGRAD (2019)

Analysing Temperature Effects with a Mobile and Precise Gradient Device

Read More  

ph-coding (2019)

Predictive Haptic COding Devices In Next Generation interfaces

Read More